127 related articles for article (PubMed ID: 34244048)
1. Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status.
Gesteiro E; Megía A; Guadalupe-Grau A; Fernandez-Veledo S; Vendrell J; González-Gross M
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2557-2574. PubMed ID: 34244048
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and secular trends in premetabolic syndrome in the United States: Findings from 1999-2020 nationally representative data of adults.
Amuda O; Okosun BO; Abdi H; Okosun IS
Ann Epidemiol; 2024 May; 93():10-18. PubMed ID: 38494039
[TBL] [Abstract][Full Text] [Related]
3. The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults.
Papadaki A; Nolen-Doerr E; Mantzoros CS
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33143083
[TBL] [Abstract][Full Text] [Related]
4. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
Feldman RA; O'Neill K; Butts SF; Dokras A
Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
[TBL] [Abstract][Full Text] [Related]
5. Serum vitamin D concentrations are inversely related to prevalence of metabolic syndrome in Qatari women.
Ganji V; Sukik A; Alaayesh H; Rasoulinejad H; Shraim M
Biofactors; 2020 Jan; 46(1):180-186. PubMed ID: 31512799
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
7. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial Factors in the Relationship between Socioeconomic Status and Cardiometabolic Risk: the HCHS/SOL Sociocultural Ancillary Study.
McCurley JL; Penedo F; Roesch SC; Isasi CR; Carnethon M; Sotres-Alvarez D; Schneiderman N; Gonzalez P; Chirinos DA; Camacho A; Teng Y; Gallo LC
Ann Behav Med; 2017 Aug; 51(4):477-488. PubMed ID: 28130624
[TBL] [Abstract][Full Text] [Related]
9. Associations between metabolic syndrome components and markers of inflammation in Welsh school children.
Thomas NE; Rowe DA; Murtagh EM; Stephens JW; Williams R
Eur J Pediatr; 2018 Mar; 177(3):409-417. PubMed ID: 29273941
[TBL] [Abstract][Full Text] [Related]
10. Uric Acid in Metabolic and Cerebrovascular Disorders: A Review.
Cortese F; Scicchitano P; Cortese AM; Meliota G; Andriani A; Truncellito L; Calculli G; Giordano P; Ciccone MM
Curr Vasc Pharmacol; 2020; 18(6):610-618. PubMed ID: 31845632
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality.
Wlodzimirow KA; Eslami S; Abu-Hanna A; Nieuwoudt M; Chamuleau RA
Liver Int; 2013 Jan; 33(1):40-52. PubMed ID: 22429562
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
[TBL] [Abstract][Full Text] [Related]
13. Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis.
Pan X; Wen SW; Bestman PL; Kaminga AC; Acheampong K; Liu A
PLoS One; 2020; 15(3):e0229776. PubMed ID: 32134969
[TBL] [Abstract][Full Text] [Related]
14. Association between serum activin A and metabolic syndrome in older adults: Potential of activin A as a biomarker of cardiometabolic disease.
Peng LN; Chou MY; Liang CK; Lee WJ; Kojima T; Lin MH; Loh CH; Chen LK
Exp Gerontol; 2018 Oct; 111():197-202. PubMed ID: 30071284
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin D supplementation on markers of cardiometabolic risk in children and adolescents: A meta-analysis of randomized clinical trials.
Cai B; Luo X; Zhang P; Luan Y; Cai X; He X
Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2800-2814. PubMed ID: 34353700
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Metabolic Syndrome in Morbidly Obese Subjects.
Dusanov S; Heggen E; Tonstad S
Metab Syndr Relat Disord; 2016 Dec; 14(10):500-506. PubMed ID: 27513810
[TBL] [Abstract][Full Text] [Related]
17. Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitness in US Adults.
Ganji V; Tangpricha V; Zhang X
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32164233
[TBL] [Abstract][Full Text] [Related]
18. The effect of weight regain on cardiometabolic health in children with obesity: A systematic review of clinical studies.
Vermeiren E; Bruyndonckx L; De Winter B; Verhulst S; Van Eyck A; Van Hoorenbeeck K
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2575-2586. PubMed ID: 34172320
[TBL] [Abstract][Full Text] [Related]
19. Validation of Surrogate Anthropometric Indices in Older Adults: What Is the Best Indicator of High Cardiometabolic Risk Factor Clustering?
Ramírez-Vélez R; Pérez-Sousa MÁ; Izquierdo M; Cano-Gutierrez CA; González-Jiménez E; Schmidt-RioValle J; González-Ruíz K; Correa-Rodríguez M
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31344803
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
